Teva and other companies were accused in a lawsuit brought by the state’s attorney general in 2019 of vigorously marketing painkillers all over the state while doing nothing to prevent addiction.
The amount of money the organization would have to pay in damages will be established later.
Teva announced on Thursday that it will appeal the decision.
At trial, the drugmaker claimed that it followed all federal and state standards and that it did not engage in deceptive marketing.
The jury found the firm and its affiliates accountable for “death and destruction” across the United States, according to New York State Attorney General Laetitia James.
“Teva Pharmaceuticals USA and others lied to the American public about the true hazards of opioids,” she claimed.
Six drug makers, representatives of the Sackler family, which established Purdue Pharma, and opioid distributors were named in a lawsuit filed in 2019.
Many negotiated agreements with the govt.
Supporters of the lawsuit believe that the money Teva would have to pay in damages will go toward enhancing treatment and
support options for people who are addicted to opioids.
However, the court in the case must still evaluate Teva’s request for the case to be ruled a mistrial after a counsel for New York
used erroneous opioid prescription figures during the trial’s last arguments.
Pharmaceutical companies are accused of deceiving the public about the potential for abuse by governments and communities all around country.
Teva did not immediately reply to a request for comment, but it said in a statement to CBS that it “completely disagrees with verdict
and will prepare for a quick appeal as well as continue to pursue a mistrial.”
In the 20 years leading up to 2019, authorities estimate that almost half a million individuals died in the United States from opioid overdoses.
United States Centers for Disease Control and Prevention reported in November that 100,000 individuals died of overdoses from April 2020 to April 2021, with the results attributed in part to a major increase in the synthetic opioid fentanyl.